Atypical femoral fractures and their relation to bisphosphonate use.
Osteoporosis Clinic, Endocrinology and Diabetes Unit, Hillel Yaffe Medical Center, Hadera, Israel. lianatrish@gmail.com
Liana
L
Tripto-Shkolnik
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005264:Femoral Fractures / Q000209:etiology* / Q000473:pathology; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D013997:Time Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates